Improving cancer therapies through translational and clinical research
Translational and Clinical Oncology Research Program
This study is exploring new ways to improve cancer treatment by finding better targets and markers that can help predict how the disease will progress, so patients can receive more personalized and effective therapies.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-10933319 on NIH RePORTER |
What this research studies
The Translational and Clinical Oncology Research Program at the Sylvester Comprehensive Cancer Center focuses on advancing cancer treatment through innovative research. This program aims to identify new molecular targets and biomarkers that can enhance the prediction and prognosis of cancer, leading to more effective therapies. By leveraging collaborative efforts across various departments, the program seeks to translate scientific discoveries into clinical applications, particularly in precision medicine and immunotherapy. Patients may benefit from novel treatment strategies developed through this research.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals diagnosed with various types of cancer, particularly those who may benefit from precision medicine approaches.
Not a fit: Patients with non-cancerous conditions or those not diagnosed with specific cancers targeted by this research may not receive benefits.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer therapies and better patient outcomes.
How similar studies have performed: Other research initiatives in translational oncology have shown success in improving treatment outcomes, indicating that this approach is promising.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Landgren, Carl Ola — University of Miami School of Medicine
- Study coordinator: Landgren, Carl Ola
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.